用于免疫治疗的巨参与的双特异抗体 (pBsAbs) 通过简单的生物结合策略进行免疫治疗

Chihao Shao1, Bo Tang1, Jacky C H Chu2

  • 1Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University Kowloon Hong Kong China william-cs.tai@polyu.edu.hk w.t.wong@polyu.edu.hk clarence-tt.wong@polyu.edu.hk.

Chemical science
|July 26, 2024
PubMed
概括

一个新的双特异性抗体 (pBsAb) 平台迅速产生新的双特异性抗体. 这种方法增强了巨细胞与癌细胞的相互作用,并阻止了"不要"的作用.